Literature DB >> 10398139

Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.

U Wagner1, K Süess, T Luginbühl, U Schmid, D Ackermann, T Zellweger, R Maurer, G Alund, H Knönagel, M Rist, P Jordan, H Moch, M J Mihatsch, T C Gasser, G Sauter.   

Abstract

The biological behaviour of urinary bladder neoplasms cannot be adequately predicted by histological criteria alone. Cyclin D1 is a cell-cycle regulating protein known to be overexpressed in a proportion of bladder carcinomas. To evaluate the prognostic significance of cyclin D1 expression and its relationship with tumour phenotype, 392 bladder carcinomas were analysed by immunohistochemistry. Clinical follow-up information was available in 337 patients with superficial bladder tumours (stages pTa/pT1). Cyclin D1 positivity was seen in 176 of 392 carcinomas. Cyclin D1 overexpression was strongly linked to papillary tumour growth, low stage, and low histological grade (p<0.005 each). Multivariate analysis showed that papillary tumour growth was the only parameter which was independently linked to cyclin D1 positivity. There was no significant difference in proliferative activity (Ki67 labelling index) between cyclin D1-negative and -positive tumours. Cyclin D1 positivity was not linked to the risk of recurrence or tumour progression, either in pTa or in pT1 carcinomas. It is concluded that cyclin D1 positivity distinguishes a large subgroup of papillary bladder tumours, but there is no evidence of prognostic significance for increased cyclin D1 expression. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398139     DOI: 10.1002/(SICI)1096-9896(199905)188:1<44::AID-PATH320>3.0.CO;2-Q

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  High NF-κB and STAT3 activity in human urothelial carcinoma: a pilot study.

Authors:  Marina Degoricija; Marijan Situm; Jelena Korać; Ana Miljković; Katarina Matić; Martina Paradžik; Ivana Marinović Terzić; Ana Jerončić; Snježana Tomić; Janoš Terzić
Journal:  World J Urol       Date:  2014-01-22       Impact factor: 4.226

2.  Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma.

Authors:  Saba El-Gendi; Ghada Abu-Sheasha
Journal:  Pathol Oncol Res       Date:  2017-05-09       Impact factor: 3.201

3.  Biomarkers in bladder cancer: present status and perspectives.

Authors:  Wun-Jae Kim; Soongang Park; Yong-June Kim
Journal:  Biomark Insights       Date:  2007-03-27

4.  Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization.

Authors:  J Richter; L Beffa; U Wagner; P Schraml; T C Gasser; H Moch; M J Mihatsch; G Sauter
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

5.  Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.

Authors:  A A Khan; P D Abel; K S Chaudhary; Z Gulzar; G W H Stamp; E-N Lalani
Journal:  Mol Pathol       Date:  2003-12

6.  Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin.

Authors:  Sultan S Alkhateeb; Mischel Neill; Sas Bar-Moshe; Bas Van Rhijn; David M Kakiashvili; Neil Fleshner; Michael Jewett; Michel Petein; Claude Schulman; Sally Hanna; Peter J Bostrom; Thierry Roumeguere; Shahrokh F Shariat; Sandrine Rorive; Alexandre R Zlotta
Journal:  Urol Ann       Date:  2011-09

7.  Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.

Authors:  J Edwards; P Duncan; J J Going; K M Grigor; A D Watters; J M Bartlett
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

Review 8.  Phytosterols in Seaweeds: An Overview on Biosynthesis to Biomedical Applications.

Authors:  Soo-In Sohn; Periyasamy Rathinapriya; Sekaran Balaji; Devasahayam Jaya Balan; Thirukannamangai Krishnan Swetha; Ravindran Durgadevi; Selvaraj Alagulakshmi; Patchiappan Singaraj; Subramani Pandian
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

9.  Impaired delta NP63 expression is associated with poor tumor development in transitional cell carcinoma of the bladder.

Authors:  Yunfeng He; Xiaohou Wu; Wei Tang; Daiyin Tian; Chunli Luo; Zhikang Yin; Hu Du
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.